Cargando…

Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?

BACKGROUND: Progression of the disease in idiopathic pulmonary fibrosis (IPF) is difficult to predict, due to its variable and heterogenous course. The relationship between radiographic progression and functional decline in IPF is unclear. We sought to confirm that a simple HRCT fibrosis visual scor...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Nada, D’Amato, Dejanira, Hosein, Karishma, Ranalli, Tiziana, Sergiacomi, Gianluigi, Zompatori, Maurizio, Mura, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238541/
https://www.ncbi.nlm.nih.gov/pubmed/32429952
http://dx.doi.org/10.1186/s12931-020-01371-7
_version_ 1783536551771242496
author Taha, Nada
D’Amato, Dejanira
Hosein, Karishma
Ranalli, Tiziana
Sergiacomi, Gianluigi
Zompatori, Maurizio
Mura, Marco
author_facet Taha, Nada
D’Amato, Dejanira
Hosein, Karishma
Ranalli, Tiziana
Sergiacomi, Gianluigi
Zompatori, Maurizio
Mura, Marco
author_sort Taha, Nada
collection PubMed
description BACKGROUND: Progression of the disease in idiopathic pulmonary fibrosis (IPF) is difficult to predict, due to its variable and heterogenous course. The relationship between radiographic progression and functional decline in IPF is unclear. We sought to confirm that a simple HRCT fibrosis visual score is a reliable predictor of mortality in IPF, when longitudinally followed; and to ascertain which pulmonary functional variables best reflect clinically significant radiographic progression. METHODS: One-hundred-twenty-three consecutive patients with IPF from 2 centers were followed for an average of 3 years. Longitudinal changes of HRCT fibrosis scores, forced vital capacity (FVC), total lung capacity and diffusing lung capacity for carbon monoxide were considered. HRCTs were scored by 2 chest radiologists. The primary outcome was lung transplant (LTx)-free survival after the follow-up HRCT. RESULTS: During the follow-up period, 43 deaths and 11 LTx occurred. On average, the HRCT fibrosis score increased significantly, and a longitudinal increase > 7% predicted LTx-free survival significantly, with good specificity, but limited sensitivity. The correlation between radiographic and functional progression was moderately significant. HRCT progression and FVC decline predicted LTx-free survival independently and significantly, with better sensitivity, but worse specificity for a ≥ 5% decline of FVC. However, the area under the curve towards LTx-survival were only 0.61 and 0.62, respectively. CONCLUSIONS: The HRCT fibrosis visual score is a reliable and responsive tool to detect clinically meaningful disease progression. Although no individual pulmonary function test closely reflects radiographic progression, a longitudinal FVC decline improves sensitivity in the detection of clinically significant disease progression. However, the accuracy of these methods remains limited, and better prognostication models need to be found.
format Online
Article
Text
id pubmed-7238541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72385412020-05-27 Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Taha, Nada D’Amato, Dejanira Hosein, Karishma Ranalli, Tiziana Sergiacomi, Gianluigi Zompatori, Maurizio Mura, Marco Respir Res Research BACKGROUND: Progression of the disease in idiopathic pulmonary fibrosis (IPF) is difficult to predict, due to its variable and heterogenous course. The relationship between radiographic progression and functional decline in IPF is unclear. We sought to confirm that a simple HRCT fibrosis visual score is a reliable predictor of mortality in IPF, when longitudinally followed; and to ascertain which pulmonary functional variables best reflect clinically significant radiographic progression. METHODS: One-hundred-twenty-three consecutive patients with IPF from 2 centers were followed for an average of 3 years. Longitudinal changes of HRCT fibrosis scores, forced vital capacity (FVC), total lung capacity and diffusing lung capacity for carbon monoxide were considered. HRCTs were scored by 2 chest radiologists. The primary outcome was lung transplant (LTx)-free survival after the follow-up HRCT. RESULTS: During the follow-up period, 43 deaths and 11 LTx occurred. On average, the HRCT fibrosis score increased significantly, and a longitudinal increase > 7% predicted LTx-free survival significantly, with good specificity, but limited sensitivity. The correlation between radiographic and functional progression was moderately significant. HRCT progression and FVC decline predicted LTx-free survival independently and significantly, with better sensitivity, but worse specificity for a ≥ 5% decline of FVC. However, the area under the curve towards LTx-survival were only 0.61 and 0.62, respectively. CONCLUSIONS: The HRCT fibrosis visual score is a reliable and responsive tool to detect clinically meaningful disease progression. Although no individual pulmonary function test closely reflects radiographic progression, a longitudinal FVC decline improves sensitivity in the detection of clinically significant disease progression. However, the accuracy of these methods remains limited, and better prognostication models need to be found. BioMed Central 2020-05-19 2020 /pmc/articles/PMC7238541/ /pubmed/32429952 http://dx.doi.org/10.1186/s12931-020-01371-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Taha, Nada
D’Amato, Dejanira
Hosein, Karishma
Ranalli, Tiziana
Sergiacomi, Gianluigi
Zompatori, Maurizio
Mura, Marco
Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title_full Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title_fullStr Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title_full_unstemmed Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title_short Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
title_sort longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238541/
https://www.ncbi.nlm.nih.gov/pubmed/32429952
http://dx.doi.org/10.1186/s12931-020-01371-7
work_keys_str_mv AT tahanada longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT damatodejanira longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT hoseinkarishma longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT ranallitiziana longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT sergiacomigianluigi longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT zompatorimaurizio longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters
AT muramarco longitudinalfunctionalchangeswithclinicallysignificantradiographicprogressioninidiopathicpulmonaryfibrosisarewefollowingtherightparameters